Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- New Haven, Connecticut
- Most recent report
- 10-Q, filed Nov 9, 2026
- Incorporated
- Delaware
- Filings on record
- 539 filings
- On EDGAR
- CIK 1563880
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 31
News 8 of 81
Prospectuses and Registrations 8 of 34
- S-8 Registration statement for an employee plan Aug 6, 2026
- 424B5 Prospectus supplement for an offering Apr 17, 2026
- 424B5 Prospectus supplement for an offering Apr 16, 2026
- S-3ASR Automatic shelf registration Nov 13, 2025
- S-8 Registration statement for an employee plan Aug 7, 2025
- 424B5 Prospectus supplement for an offering Jun 4, 2025
- 424B5 Prospectus supplement for an offering Jun 2, 2025
- S-8 Registration statement for an employee plan Mar 18, 2025
Proxies 8 of 17
- DEF 14A Proxy statement for a shareholder vote Apr 21, 2026
- DEFA14A Extra proxy material Apr 21, 2026
- PRE 14A Preliminary proxy statement Apr 10, 2026
- DEFA14A Extra proxy material Apr 29, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2025
- DEFA14A Extra proxy material Apr 26, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 26, 2024
- DEFA14A Extra proxy material May 1, 2023
Ownership 8 of 332
- SCHEDULE 13G/A Large holder reported a passive stake, amended Oct 27, 2026
- 4 Insider reported a trade Sep 17, 2026
- 144 Notice of a proposed sale of restricted stock Sep 15, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 6, 2026
- 4 Insider reported a trade Jun 4, 2026
- 4 Insider reported a trade Jun 4, 2026
- 4 Insider reported a trade Jun 4, 2026
- 4 Insider reported a trade Jun 4, 2026
Other 8 of 44
- ARS Annual report sent to shareholders Apr 21, 2026
- ARS Annual report sent to shareholders Apr 29, 2025
- ARS Annual report sent to shareholders Apr 29, 2024
- EFFECT Notice that a registration became effective Aug 15, 2023
- CORRESP Reply to SEC staff Aug 14, 2023
- UPLOAD Comment letter from SEC staff Jul 5, 2023
- ARS Annual report sent to shareholders May 1, 2023
- EFFECT Notice that a registration became effective May 11, 2022
Everything here comes from Trevi Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.